
Cell signaling pathways regulate essential processes such as growth, differentiation, and programmed cell death. Dysregulation of these pathways contributes to disease development, including cancer, autoimmune disorders, and neurological conditions. A systematic and reliable analysis of these pathways is therefore critical for uncovering mechanisms of disease and guiding therapeutic innovation.
With Hyperplex™, Assay Engineers provides comprehensive coverage of all major signaling pathways. Our platform combines high-quality sample testing with rigorous statistical evaluation, ensuring results that are reproducible and scientifically robust. Each dataset is interpreted against peer-reviewed, validated pathway information, delivering findings that can be trusted in early-stage drug discovery and translational research.
By translating complex biomarker concentration ratios into validated functional information, Hyperplex™ enables the discovery of dysregulated pathways and clinically relevant markers. This structured approach enables researchers to pinpoint cellular mechanisms that matter most, prioritize drug targets with confidence, and design more effective preclinical studies. These predictive, data-driven results strengthen translational research and accelerate early drug development.
Main Benefit
Strengthen the bridge between preclinical findings and clinical relevance through pathway-validated biomarker analysis.
Schedule an individual life event with a scientist at Assay Engineers to identify your markers of interest.